0.5088USD+1.76%Mkt Cap: 19.72M USDP/E: —Last update: 2026-05-26
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral s…
Industry Peers
Biotechnology110.61BUSDP/E 25.8
105.81BDKKP/E 20.4
66.47BUSDP/E 15.5
46.56BEURP/E 30.5
43.89BEURP/E 36.5
39.41BUSDP/E 74.0
32.84BUSD—
32.05BSEKP/E 47.4
Indicators:|
Key Statistics
Company
Market Cap19.72M USD
Enterprise Value-4.18M USD
Revenue (TTM)7.06M USD
Gross Profit9.40M USD
Net Income (TTM)-7.58M USD
Revenue/Share0.4450 USD
Last Price0.5088 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees20
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.41
PEG—
EV/EBITDA0.12
EV/Revenue-0.59
P/S2.70
P/B0.75
EPS (TTM)-0.58
EPS (Forward)-1.19
52W Range
0.46002% of range3.130
52W High3.130 USD
52W Low0.4600 USD
Profitability
Gross Margin99.52%
Oper. Margin-485.12%
EBITDA Margin0.00%
Profit Margin-80.29%
ROE-138.81%
ROA-37.97%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-27.20M USD
CapEx (TTM)—
FCF Margin—
FCF Yield—
Net Debt-13.66M USD
Net Debt/EBITDA0.40
Balance Sheet
Debt/Equity0.30
Current Ratio1.22
Quick Ratio0.96
Book Value/Sh0.6560 USD
Cash/Share0.7750 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateMay 30, 2018
Splits
Last Split1:5
Split DateMay 30, 2018
Analyst Consensus
Rating1.3 (Strong Buy)
Target (Mean)14.00 USD
Target Range5.000 USD – 20.00 USD
# Analysts3
Ownership
Shares Out.38.98M
Float16.03M
Insiders7.95%
Institutions40.50%
Short Interest
Short Ratio0.3d
Short % Float0.66%
Short % Out.0.66%
Shares Short262.33K
Short (prev mo.)62.94K
Technical
SMA 500.6132 (-17.0%)
SMA 2001.145 (-55.5%)
Beta—
S&P 52W Chg28.31%
Avg Vol (30d)465.68K
Avg Vol (10d)249.56K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—